Trial NCT02299635

View at ClinicalTrials.gov 
Org. Study IDs: A8641020
Secondary IDs: 2014-002286-30

Last trial update was posted on 2019-01-08

MeSH Interventions

Nirogacestat

MeSH Conditions

Breast Neoplasms Triple Negative Breast Neoplasms

Other Conditions


Stopping Reasons

The study was terminated on June 24th, 2015 due to change in strategy of PF-03084014 development. There were no safety/efficacy concerns behind the decision.

Limitations And Caveats

This study was terminated prematurely based on project re-prioritization by the Sponsor and was not due to any safety concerns or regulatory actions.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID